Evidence map›Paper›PMID 28368377›Full record

Trial reportBone marrow transplantation2017

Prognostic impact of the European LeukemiaNet standardized reporting system in older AML patients receiving stem cell transplantation after non-myeloablative conditioning.

M Bill, M Jentzsch, J Grimm, K Schubert, T Lange, M Cross, G Behre, V Vucinic, W Pönisch, G-N Franke and 2 more

Abstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prognostic Impact of BloodHemaSphere · 2019
    Article
  10. Article
  11. HighOncotarget · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M BillDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
M JentzschDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
J GrimmDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
K SchubertDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
T LangeDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
M CrossDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
G BehreDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
V VucinicDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
W PönischDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
G-N FrankeDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
D NiederwieserDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
S SchwindDepartment of Hematology and Oncology, University of Leipzig, Leipzig, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medical Records Systems, ComputerizedStem Cell TransplantationTransplantation ConditioningAgedEuropeFemaleFollow-Up StudiesHumansLeukemia, Myeloid, AcuteMaleMiddle AgedPrognosisRetrospective Studies

Identifiers

PMID28368377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.